The fibrinogen Aα R16C mutation results in fibrinolytic resistance

British Journal of Haematology

Volumn 134, Issue 2, 2006, Pages 220-226

  Flood, Veronica H ^a   Al Mondhiry, Hamid A ^b   Farrell, David H ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Coagulation factors; Fibrinogen; Fibrinolysis; Genetic disorders; Paediatric haemostasis

Indexed keywords

ALBUMIN; ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR; FIBRINOGEN; FIBRINOGEN AALPHA; FIBRINOGEN BBETA; FIBRINOGEN GAMMA; FIBRINOGEN HERSHEY III; PLASMIN; PLASMINOGEN; TRYPSIN; UNCLASSIFIED DRUG; FIBRIN; FIBRINOGEN VARIANT;

ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD CLOTTING; CASE REPORT; DYSFIBRINOGENEMIA; FIBRINOLYSIS; GENE MUTATION; HETEROZYGOTE; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; PHENOTYPE; PLASMINOGEN ACTIVATION; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PURIFICATION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; BLOOD; BLOOD CLOTTING DISORDER; GENETICS; METABOLISM; MUTATION;

CHILD, PRESCHOOL; COAGULATION PROTEIN DISORDERS; FIBRIN; FIBRINOGEN; FIBRINOGENS, ABNORMAL; FIBRINOLYSIS; HETEROZYGOTE; HUMANS; MALE; MUTATION;

EID: 33745158288     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06129.x     Document Type: Article

References (33)

1. Acharya S.S. Coughlin A. DiMichele D.M. North American Rare Bleeding Disorder Study Group. ( 2004) Rare bleeding disorder registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. Journal of Thrombosis and Haemostasis, 2, 248 256.
2. Al-Mondhiry H. Galanakis D. ( 1987) Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis. Journal of Laboratory and Clinical Medicine, 110, 726 733.
3. Chung D.W. Harris J.E. Davie E.W. ( 1990) Nucleotide sequences of the three fibrinogen genes coding for human fibrinogen. In : Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis ( ed. by C.Y. Liu S. Chien pp. 39 48. Plenum Press, New York.
4. Collen D. Lijnen H.R. ( 2004) Tissue-type plasminogen activator: a historical perspective and personal account. Journal of Thrombosis and Haemostasis, 2, 541 546.
5. Collet J.P. Soria J. Mirshahi M. Hirsch M. Dagonnet F.B. Caen J. Soria C. ( 1993) Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure. Blood, 82, 2462 2469.
6. Collet J.P. Park D. Lesty C. Soria J. Soria C. Montalescot G. Weisel J.W. ( 2000) Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 1354 1361.
7. Côté H.C. Lord S.T. Pratt K.P. ( 1998) γ-chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the γ chain of human fibrinogen. Blood, 92, 2195 2212.
8. Doolittle R.F. ( 2003) X-ray crystallographic studies on fibrinogen and fibrin. Journal of Thrombosis and Haemostasis, 1, 1559 1565.
9. Everse S.J. Spraggon G. Doolittle R.F. ( 1998) A three-dimensional consideration of variant human fibrinogens. Thrombosis and Haemostasis, 80, 1 9.
10. Falls L.A. Farrell D.H. ( 1997) Resistance of γA/γ′ fibrin clots to fibrinolysis. Journal of Biological Chemistry, 272, 14251 14256.
11. Gabriel D.A. Muga K. Boothroyd E.M. ( 1992) The effect of fibrin structure on fibrinolysis. Journal of Biological Chemistry, 267, 24259 24263.
12. Galanakis D.K. Lane B.P. Simon S.R. ( 1987) Albumin modulates lateral assembly of fibrin polymers: evidence of enhanced fine fibril formation and of unique synergism with fibrinogen. Biochemistry, 26, 2389 2400.
13. Galanakis D.K. Henschen A. Peerschke E.I. Kehl M. ( 1989) Fibrinogen Stony Brook, a heterozygous Aα16Arg→Cys dysfibrinogenemia. Journal of Clinical Investigation, 84, 295 304.
14. Galanakis D.K. Henschen A. Schuback W. Lord S. Al-Mondhiry H. ( 1990) Two abnormal Aα16Arg→Cys dysfibrinogens, Hershey II and Leogan: determination of abnormal structure and heterozygosity by amplification of genomic DNA using the polymerase chain reaction and by amino acid sequence analyses. In : Fibrinogen-Current Basic and Clinical Aspects ( ed. by M. Matsuda S. Iwanaga A. Takada pp. 173 178. Elsevier Science, Kyoto, Japan.
15. Guthold M. Liu W. Stephens B. Lord S.T. Hantgan R.R. Erie D.A. Taylor Jr., R.M. Superfine R. ( 2004) Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1·3. Biophysical Journal, 87, 4226 4236.
16. Hanss M. Biot F. ( 2001) A database for human fibrinogen variants. Annals of the New York Academy of Sciences, 936, 89 90 Available at: http://www.geht.org/databaseang/fibrinogen [last accessed 5 May 2006].
17. Haverkate F. Samama M. ( 1995) Familial dysfibrinogenemia and thrombophilia. Thrombosis and Haemostasis, 73, 151 161.
18. Henschen A. Kehl M. Southan C. Lottspeich F. Georgopoulos D. ( 1983) Genetically abnormal fibrinogens-some current characterisation strategies. In : Fibrinogen: Structure, Functional Aspects, Metabolism, Vol. 2 ( ed. by F. Haverkate A. Henschen W. Nieuwenhuizen P.W. Straub pp. 125 144. Walter de Gruyter & Co., Berlin.
19. Kazal L.A. Amsel S. Miller O.P. Tocantins L.M. ( 1963) The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proceedings of the Society for Experimental Biology and Medicine, 113, 989 994.
20. Laemmli U.K. ( 1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680 685.
21. Lee M.H. Kaczmarek E. Chin D.T. Oda A. McIntosh S. Bauer K.A. Clyne L.P. McDonagh J. ( 1991) Fibrinogen Ledyard (Aα Arg16→Cys): biochemical and physiologic characterization. Blood, 78, 1744 17452.
22. Lorand L. ( 2005) Factor XIII and the clotting of fibrinogen: from basic research to medicine. Journal of Thrombosis and Haemostasis, 3, 1337 1348.
23. Matsuda M. Sugo T. Yoshida N. Terukina S. Yamazumi K. Niwa K. Maekawa H. ( 1999) Structure and function of fibrinogen: insights from dysfibrinogens. Thrombosis and Haemostasis, 82, 283 290.
24. Medved L. Nieuwenhuizen W. ( 2003) Molecular mechanisms of initiation of fibrinolysis by fibrin. Thrombosis and Haemostasis, 89, 409 419.
25. Miyata T. Terukina S. Matsuda M. Kasamatsu A. Takeda Y. Murakami T. Iwanaga S. ( 1987) Fibrinogens Kawaguchi and Osaka: an amino acid substitution of Aα arginine-16 to cysteine which forms an extra interchain disulfide bridge between the two Aα chains. Journal of Biochemistry (Tokyo), 102, 93 101.
26. Moaddel M. Falls L.A. Farrell D.H. ( 2000) The role of γA/γ' fibrinogen in plasma factor XIII activation. Journal of Biological Chemistry, 275, 32135 32140.
27. Mosesson M. ( 1999) Dysfibrinogenemia and thrombosis. Seminars in Thrombosis and Hemostasis, 25, 311 319.
28. Sakata Y. Aoki N. ( 1980) Cross-linking of α2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. Journal of Clinical Investigation, 65, 290 297.
29. Soria J. Soria C. Samama M. Henschen A. Southan C. ( 1982) Detection of fibrinogen abnormality in dysfibrinogenemia: special report on fibrinogen Metz characterized by an amino acid substitution located at the peptide bond cleaved by thrombin. In : Fibrinogen: Recent Biochemical and Medical Aspects ( ed. by A. Henschen H. Graeff F. Lottspeich pp. 129 143. Walter de Gruyter & Co., Berlin.
30. Southan C. Lane D.A. Henschen A. ( 1983) Functional characterisation and protein chemical analysis of two new cases of dysfibrinogenemia, London III and IV. In : Fibrinogen: Structure, Functional Aspects, Metabolism, Vol. 2 ( ed. by F. Haverkate A. Henschen W. Nieuwenhuizen P.W. Straub pp. 167 182. Walter de Gruyter & Co., Berlin.
31. Stucki B. Zenhäusern R. Biedermann B. Baudo F. Redaelli R. Lämmle B. Furlan M. ( 1999) Fibrinogens Bern IV, Bern V, and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aα chain. Blood Coagulation & Fibrinolysis, 10, 93 99.
32. Torbet J. ( 1986) Fibrin assembly in human plasma and fibrinogen/albumin mixtures. Biochemistry, 25, 5309 5314.
33. Weisel J.W. ( 2005) Fibrinogen and fibrin. Advances in Protein Chemistry, 70, 247 299.